| Revenue growth | +50% y-o-y to INR 68.9 cr |
|---|---|
| Margins | EBITDA margin 18.0% vs 21.7% H1 FY26 |
Growth
Revenue +50% y-o-y to ₹68.9 cr; EBITDA +25% to ₹12.4 cr; PAT +43% to ₹7.8 cr. Home & Personal Care up 35% to ₹9.8 cr.
Outlook
No numerical guidance given. Priorities: export expansion, new launches, Home & Personal Care growth, bio-based portfolio.
Risks
EBITDA margin down 370 bps y-o-y. Net debt/equity rose to 0.38x from 0.22x. H1 operating cash flow negative at ₹-1.0 cr.
Investor Presentation filed with NSE, NSE: NEOCHEM. Summary written with AI assistance from the document.
Neochem Bio Solutions Ltd: key numbers
- Share price
- ₹105.10
- Market cap
- ₹179.9 Cr
- Revenue (annual)
- ₹110.7 Cr
- Net profit (annual)
- ₹12.03 Cr
- P/E (TTM)
- 15.0×Sector 34.1×
- Promoter holding
- 66.88%
- FII holding
- 0.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neochem Bio Solutions Ltd
All →Neochem Bio Solutions Earnings Call Transcript: Key Takeaways
Neochem Bio Solutions is a specialty chemical manufacturer reporting strong H1 FY25 growth, achieving ₹4,718 Lakh income with 18.75% EBITDA margin, focusing on Textile, HPC, and sustainable bio-based formulations.
Neochem Bio Solutions Management Change
Neochem Bio Solutions appointed Harshit Shah as CFO and Vikram Nair as CCO effective October 27. Solanki was redesigned from CFO to Senior VP Finance.
Neochem Bio Solutions H1 FY27 Results: Net Profit ₹7.8 Cr, Up 41.8% YoY
Neochem Bio Solutions Ltd reported revenue from operations of ₹68.9 Cr (+50.4% YoY) and net profit of ₹7.8 Cr (+41.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹7.8 Cr · +41.8% YoY
Neochem Bio Solutions Other Announcement
Neochem Bio Solutions Limited submitted its Structured Digital Database (SDD) compliance certificate for the quarter and half-year ended September 30, 2026, as per SEBI regulations.
Neochem Bio Solutions Annual General Meeting
Neochem Bio Solutions Limited held its 9th Annual General Meeting on September 21, 2026, where management reviewed the company's performance and discussed future business strategies.
Neochem Bio Solutions Promoter Buying: ₹0.14 Cr
Promoter Swapnil R. Makati acquired 1,200 equity shares of Neochem Bio Solutions Limited for ₹0.14 Crore via an on-market purchase.
- Value
- ₹0.14 Cr
- Promoter stake change
- +0.01%